The history of the Thalidomide tragedy
The legacy of Thalidomide will always remain a part of our company’s history. We will never forget what happened, and we deeply regret the wide-ranging consequences for the people affected and their families. On this page, you will find information about Thalidomide and how Grünenthal currently provides support to Thalidomide-affected people.
“We deeply regret the severe consequences of the Thalidomide tragedy. We take our responsibility towards those affected very seriously and provide concrete support in their everyday lives.”
Information about the Thalidomide tragedy
Thalidomide: The medication and its consequences
Our responsibility: How Grünenthal supports people affected by Thalidomide today
Grünenthal Foundation
News and current developments
12/20/2023
Grünenthal welcomes national apology for Thalidomide survivors by Australian Prime Minister
On November 29th, 2023, Australian Prime Minister Anthony Albanese issued an apology in the name of the Australian Parliament for the role of the Australian government in the thalidomide tragedy. The apology was addressed at Australian thalidomide survivors, who have been campaigning for recognition for years.
More11/27/2021
60 Years after the market withdrawal: Dr. Michael Wirtz apologises to those affected on behalf of his family
On the occasion of 60 years after the market withdrawal of Thalidomide, Dr. Michael Wirtz, shareholder of Grünenthal, apologised to those affected and their families on behalf of his family. As company, we welcome this step.
MoreContact
Contact information for journalists and Thalidomide-affected people
Fabia Kehren
Contact for the public
Global Communications Grünenthal GmbH
Phone +49 (0) 241 569 3269
E-Mail Fabia.Kehren@grunenthal.com
Tom Hermes
Contact for people affected by Thalidomide
The Grünenthal Foundation for the Support of Thalidomide-Affected People
Phone +49 (0) 241 569 2742